MiR-532-3p inhibited the methylation of SOCS2 to suppress the progression of PC by targeting DNMT3A
Sign Up to like & getrecommendations! Published in 2023 at "Life Science Alliance"
DOI: 10.26508/lsa.202201703
Abstract: MiR-532-3p has a low expression in pancreatic cancer, but its overexpression can inhibit the tumor progression via DNMT3A-dependent inhibition of SOCS2 methylation. Pancreatic cancer (PC) is one of the deadliest malignancies, with poor diagnosis and… read more here.
Keywords: methylation socs2; socs2; overexpression; mir 532 ... See more keywords